Ligand validation:6G2Z

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6G2Z_MPD_A_802	13%	80%	0.301	0.847	0.29	0.54	-	-	2	0	100%	1
6G2Z_MPD_A_804	11%	84%	0.229	0.748	0.29	0.47	-	-	0	0	100%	1
6G2Z_MPD_A_803	11%	91%	0.298	0.812	0.31	0.26	-	-	2	0	100%	1
6G2Z_MPD_A_801	2%	78%	0.3	0.563	0.33	0.56	-	-	2	0	100%	1
6G2X_MPD_A_802	47%	80%	0.181	0.919	0.31	0.53	-	-	2	0	100%	1
6G2W_MPD_A_802	6%	70%	0.36	0.803	0.27	0.88	-	-	3	0	100%	1
4QSR_MPD_A_1204	96%	63%	0.078	0.99	0.55	0.84	-	-	0	0	100%	1
3BUI_MPD_A_1048	95%	60%	0.069	0.974	0.57	0.95	-	-	0	1	100%	1
4WPG_MPD_A_301	95%	47%	0.056	0.958	0.43	1.57	-	3	1	0	100%	1
3GWZ_MPD_D_353	94%	90%	0.056	0.953	0.31	0.29	-	-	0	0	100%	1
6JOW_MPD_B_901	93%	71%	0.066	0.962	0.34	0.77	-	-	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.